This research identifies a mechanism that regulates critical intercellular interactions within the CNS leukemia niche and supports the targeting of CD99 as a potential approach for overcoming meningeal-mediated leukemia chemoresistance [108] (Figure 5). This evidence concerns the gene CD99 and leukemia.